Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
- DOI
- 10.1016/j.jtha.2024.04.001
- Published
- 2024 Jul
- Container
- Journal of thrombosis and haemostasis : JTH
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtha.2024.04.001,
title = {Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.},
author = {Madan B and Ozelo MC and Raheja P and Symington E and Quon DV and Leavitt AD and Pipe SW and Lowe G and Kenet G and Reding MT and Mason J and Wang M and von Drygalski A and Klamroth R and Shapiro S and Chambost H and Dunn AL and Oldenburg J and Chou SC and Peyvandi F and Millar CM and Osmond D and Yu H and Dashiell-Aje E and Robinson TM and Mahlangu J},
year = {2024},
journal = {Journal of thrombosis and haemostasis : JTH},
doi = {10.1016/j.jtha.2024.04.001},
url = {https://doi.org/10.1016/j.jtha.2024.04.001}
}RIS
TY - JOUR TI - Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A. AU - Madan B AU - Ozelo MC AU - Raheja P AU - Symington E AU - Quon DV AU - Leavitt AD AU - Pipe SW AU - Lowe G AU - Kenet G AU - Reding MT AU - Mason J AU - Wang M AU - von Drygalski A AU - Klamroth R AU - Shapiro S AU - Chambost H AU - Dunn AL AU - Oldenburg J AU - Chou SC AU - Peyvandi F AU - Millar CM AU - Osmond D AU - Yu H AU - Dashiell-Aje E AU - Robinson TM AU - Mahlangu J PY - 2024 JO - Journal of thrombosis and haemostasis : JTH DO - 10.1016/j.jtha.2024.04.001 UR - https://doi.org/10.1016/j.jtha.2024.04.001 ER -
APA
B, M., MC, O., P, R., E, S., DV, Q., AD, L., SW, P., G, L., G, K., MT, R., J, M., M, W., A, V. D., R, K., S, S., H, C., AL, D., J, O., SC, C., F, P., CM, M., D, O., H, Y., E, D., TM, R., & J, M. (2024). Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.. Journal of thrombosis and haemostasis : JTH. https://doi.org/10.1016/j.jtha.2024.04.001
Source records
- pubmed · retrieved 2026-09-26T16:43:34.398Z
- europe-pmc · retrieved 2026-09-26T16:43:34.421Z
- hal · retrieved 2026-09-26T16:43:34.432Z